gatifloxacin has been researched along with Liver Diseases in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Liver Diseases: Pathological processes of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
" All treatment-emergent adverse events were mild or moderate in intensity and resolved before subjects were discharged from the study." | 1.31 | Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment. ( Christofalo, B; Duncan, G; Grasela, DM; Kollia, GD; LaCreta, FP; Manning, JA; Noveck, R, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grasela, DM | 1 |
Christofalo, B | 1 |
Kollia, GD | 1 |
Duncan, G | 1 |
Noveck, R | 1 |
Manning, JA | 1 |
LaCreta, FP | 1 |
1 other study available for gatifloxacin and Liver Diseases
Article | Year |
---|---|
Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment.
Topics: Adult; Anti-Infective Agents; Area Under Curve; Case-Control Studies; Female; Fluoroquinolones; Gati | 2000 |